Imprimer

6-Aminonicotinamide, poudre cristalline jaune pâle

Marques : MP Biomedicals
Ratings: Ecrire un avis

Total Evaluation: 0
Moyenne des Notes : 0.0 sur 5

Danger

0215010305 0215010301
ICNA0215010305EA 558 EUR
ICNA0215010305 ICNA0215010301
6-Aminonicotinamide, poudre cristalline jaune pâle
6-Aminonicotinamide

6-Aminonicotinamide was found to inhibit NADP+-dependent enzyme, 6-phosphogluconate dehydrogenase.


6-AN interferes with glycolysis, resulting in ATP depletion and synergizes with DNA-crosslinking chemotherapy drugs, like cisplatin, in killing cancer cells (IC50 = 0.5 mM). 6-AN also reduces cardiovascular oxidative injury following ischemia/reperfusion. In addition, 6-AN causes glial neurodegeneration.

Formule: C₆H₇N₃O
Température de stockage: Température ambiante
Numéro MDL: MFCD00006327
Numéro CAS: 329-89-5
EINECS: 206-349-7

Commander maintenant

Résultats des tests de spécification

Identity Test Passes
FTIR Conforms to Standard
Melting Point 240 - 250 °C


Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Plus About VWR